New Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental Biology

Scientists rise up against statistical significance

(2019) Valentin Amrhein et al.   NATURE

The False Positive Risk: A Proposal Concerning What to Do About p-Values

(2019) David Colquhoun   AMERICAN STATISTICIAN

Moving to a World Beyond “p 

(2019) Ronald L. Wasserstein et al.   AMERICAN STATISTICIAN

Moving beyond P values: data analysis with estimation graphics

(2019) Joses Ho et al.   NATURE METHODS

Desensitization of cAMP Accumulation via Human β3-Adrenoceptors Expressed in Human Embryonic Kidney Cells by Full, Partial, and Biased Agonists

(2019) Katerina Okeke et al.   Frontiers in Pharmacology

Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers

(2018) Michael J Curtis et al.   BRITISH JOURNAL OF PHARMACOLOGY

Outlier Removal in Model-Based Missing Value Imputation for Medical Datasets

(2018) Min-Wei Huang et al.   Journal of Healthcare Engineering

Commentary on the BJP 's new statistical reporting guidelines

(2018) Harvey J Motulsky et al.   BRITISH JOURNAL OF PHARMACOLOGY

The ASA's Statement onp-Values: Context, Process, and Purpose

(2016) Ronald L. Wasserstein et al.   AMERICAN STATISTICIAN

Publication Bias

(2016) Jarrod E. Dalton et al.   ANESTHESIA AND ANALGESIA

Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations

(2016) Sander Greenland et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Irreproducibility in Preclinical Biomedical Research: Perceptions, Uncertainties, and Knowledge Gaps

(2016) Michael F. Jarvis et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

The fickle P value generates irreproducible results

(2015) Lewis G Halsey et al.   NATURE METHODS

The Extent and Consequences of P-Hacking in Science

(2015) Megan L. Head et al.   PLOS BIOLOGY

Beyond Bar and Line Graphs: Time for a New Data Presentation Paradigm

(2015) Tracey L. Weissgerber et al.   PLOS BIOLOGY

The Impact of Preclinical Irreproducibility on Drug Development

(2015) LP Freedman et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The Statistical Crisis in Science

(2014) Andrew Gelman et al.   AMERICAN SCIENTIST

Policy: NIH plans to enhance reproducibility

(2014) Francis S. Collins et al.   NATURE

An investigation of the false discovery rate and the misinterpretation of p-values

(2014) D. Colquhoun   Royal Society Open Science

Do β-adrenoceptor agonists induce homologous or heterologous desensitization in rat urinary bladder?

(2013) Martin C. Michel   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Do We Really Need the S-word?

(2012) Megan Higgs   AMERICAN SCIENTIST

Raise standards for preclinical cancer research

(2012) C. Glenn Begley et al.   NATURE

Adaptive trial designs: a review of barriers and opportunities

(2012) John A Kairalla et al.   Trials

Believe it or not: how much can we rely on published data on potential drug targets?

(2011) Florian Prinz et al.   NATURE REVIEWS DRUG DISCOVERY

Circular analysis in systems neuroscience: the dangers of double dipping

(2009) Nikolaus Kriegeskorte et al.   NATURE NEUROSCIENCE

Evidence for the Efficacy of NXY-059 in Experimental Focal Cerebral Ischaemia Is Confounded by Study Quality

(2008) Malcolm R. Macleod et al.   STROKE